Search





Search





Bio-Techne Corp

TECH

Add to Watchlist

72.185USD

+0.035+0.05%

Market hours （ET）Quotes delayed by 15 min

11.30BMarket Cap

102.28P/E TTM

Bio-Techne Corp

72.185

+0.035+0.05%

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

TECH Analysis

Review the valuation, outlook, chart signals and key risks shaping Bio-Techne Corp stock.

Bio-Techne Acquired by Merck for $11.3 Billion at a Premium, Jumps Over 20% Premarket.

Bio-Techne Acquired by Merck for $11.3 Billion at a Premium, Jumps Over 20% Premarket.

TradingKey - On June 25, Eastern Time, Germany's Merck Group announced that it will acquire US life sciences company Bio-Techne (TECH) for $73 per share in an all-cash transaction, representing an enterprise value of approximately $11.3 billion.

TradingKeyThu, Jun 25